Clinical Trials

Ovarian Neoplasms

NCT07544030 2026-04-22

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

60 enrolled

Ovarian Neoplasms

NCT06430541 2026-04-21

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

20 enrolled

Breast Neoplasms, Ovarian Neoplasms

NCT06964009 2026-04-21

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

Ovarian Neoplasms

NCT07303387 2026-04-21

EZHiSWITCH

900 enrolled

Ovarian Neoplasms

NCT07340164 2026-04-20

TROY

116 enrolled

Ovarian Neoplasms, Recurrence

NCT07540403 2026-04-20

EPOCA

50 enrolled

Ovarian Neoplasms, Recurrence

NCT05051722 2026-04-17

ECHO

3,110 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Endometrial Hyperplasia, Ovarian Neoplasms, Endometrial Neoplasms

NCT06295965 2026-04-17

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

2,000 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00539162 2026-04-16

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

8,000 enrolled

Ovarian Neoplasms

NCT01907789 2026-04-16

Prophylactic Salpingectomy With Delayed Oophorectomy

80 enrolled

Ovarian Neoplasms

NCT05123807 2026-04-16

Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)

Ovarian Neoplasms

NCT06036810 2026-04-16

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

70 enrolled

Ovarian Neoplasms

NCT07303894 2026-04-16

A Study of Isoquercetin in People With Ovarian Cancer

90 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02043158 2026-04-15

Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Active not recruiting

240 enrolled

Ovarian Neoplasms

NCT03604315 2026-04-15

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03965481 2026-04-15

PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer

21 enrolled

Ovarian Neoplasms

NCT04678414 2026-04-15

Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer

Active not recruiting

1,410 enrolled

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05039801 2026-04-15

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

DermatologicGynecologicHead & NeckSarcoma

54 enrolled

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

NCT05287451 2026-04-15

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

100 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05866679 2026-04-15

Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

Phase 1 Suspended

Ovarian Neoplasms

NCT07532434 2026-04-15

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

480 enrolled

Breast Neoplasms, Ovarian Neoplasms

NCT02854215 2026-04-14

CURSOC

Phase NA Completed

200 enrolled

Ovarian Neoplasms

NCT06305299 2026-04-14

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

27 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT05183984 2026-04-13

NIRVANA-1

390 enrolled

Ovarian Neoplasms

NCT05769517 2026-04-13

PROBE-II

1,300 enrolled

Ovarian Neoplasms

NCT05887609 2026-04-13

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

53 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06710548 2026-04-13

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

240 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04878094 2026-04-09

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Phase 3 Recruiting

310 enrolled

Ovarian Neoplasms

NCT06127446 2026-04-09

The Registry of Genetic Alterations of Taiwan Ovarian Cancer

Ovarian Neoplasms

NCT06665945 2026-04-09

SENTRY

245 enrolled

Ovarian Neoplasms

NCT07000344 2026-04-09

A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor

Phase NA Terminated

5 enrolled

Phase 3 Active not recruiting

Ovarian Neoplasms

NCT03772028 2026-04-08

OVHIPEC-2

538 enrolled

Ovarian Neoplasms

NCT07282158 2026-04-08

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

25 enrolled

Phase 2 Not yet recruiting

Mental Disorders, Ovarian Neoplasms

NCT07495124 2026-04-08

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

26 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00579514 2026-04-07

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

BreastGastrointestinalGenitourinaryGynecologicThoracic

21,081 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT07035067 2026-04-07

Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

Terminated

24 enrolled

Phase 1 Active not recruiting

Caregiver Burden, Ovarian Neoplasms

NCT03017131 2026-04-06

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

9 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04294927 2026-04-06

TUBA-WISP-II

3,000 enrolled

Ovarian Neoplasms

NCT05920798 2026-04-06

FRAPPE

Phase 1/2 Recruiting

40 enrolled

Phase 2 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03428802 2026-04-03

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

21 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05752448 2026-04-03

POSTCARE-O

120 enrolled

Phase 2 Active not recruiting

Depression, Ovarian Neoplasms

NCT03355976 2026-04-02

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

46 enrolled

Phase 1 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence, Adenocarcinoma, Clear Cell

NCT06342986 2026-04-02

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

3 enrolled

Phase 2 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02873962 2026-04-01

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

72 enrolled 16 charts

Phase EARLY_PHASE1 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05080946 2026-04-01

Using Aspirin to Improve Immunological Features of Ovarian Tumors

100 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06290193 2026-04-01

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

86 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01977274 2026-03-31

GC-BIO

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07290309 2026-03-31

SURGE